Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Feb 2023 for BlackRock Health Sciences Trust. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Jeffrey Gene Lee: trading record in brief
Jeffrey Gene Lee, listed as chief executive, appears in our data through filings on BlackRock Health Sciences Trust shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 31 January 2022 and the latest from 31 January 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 2 February 2023 came the latest disclosure, an option exercise in BlackRock Health Sciences Trust. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeffrey Gene Lee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
204.568 sharesCommon StockSEC:0000899243-23-003412:0
71.445 sharesCommon StockSEC:0000899243-22-004372:0
2 of 2 declarations
